Delivery Order SPE2DR25D9127-SPE2DR26FCZA2
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,036.00 to DMS Pharmaceutical Group Inc. for ZOSYN 4.5 GM/100 ML Galaxy Bag 100ML, with an ultimate completion date of November 19, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,659.50, is for the supply of pharmaceutical products such as ZOSYN 3.375 GM/50 ML GALAXY 50ML to support the recurring medical supply needs of military health facilities worldwide. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $1,000.32 for ZOSYN 3.375 GM/50 ML Galaxy 50ML pharmaceutical product. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a single delivery order with no set-aside designation. Performance will occur at the contractor's facility in Park...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,315.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 7, 2025, covers the supply of ZOSYN 4.5 GM/100 ML in Galaxy bag format (100 ML units). The contract was issued without a set-aside designation, and performance will take place at the vendor's...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for ZOSYN 3.375 GM/50 ML Galaxy 50ML with a ceiling value of $1,351.60. This delivery order, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,622.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Zosyn 3.375 GM/50 ML Galaxy 50ML. The delivery order was issued on November 28, 2025, with an ultimate completion date of December 19, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing at its Park Ridge, Illinois location and will...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,078.70 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of a pharmaceutical product, ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML, to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $1,554.00 for ZOSYN 4.5 GM/100 ML Galaxy Bag 100ML on July 24, 2025. The contract utilizes firm fixed-price pricing with an ultimate completion date of August 14, 2025, and specifies Park Ridge, Illinois as the place of performance. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,612.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zosyn 3.375 GM/50 ML Galaxy 50ML vials. The contract was awarded on September 26, 2025, with an ultimate completion date of October 20, 2025, and carries a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $4,195.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items,...
- SPE2DR25D9127Indefinite Delivery Contract
- SPE2DR25D9127-SPE2DR26FCZA2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,000.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of ZOSYN 3.375 GM/50 ML Galaxy 50ML. This firm fixed-price delivery order, issued on December 8, 2025, with an ultimate completion date of December 30, 2025, carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, holding a single-award IDC under the PPV-G GEN V program with a ceiling value of $499.999 billion and performance extending through December 31, 2036. The company supplies an extensive portfolio of pharmaceuticals and medical consumables to military healthcare operations, including prescription medications, biologics, vaccines, and specialty pharmaceutical products. This delivery order represents routine pharmaceutical procurement activity under the broader prime vendor contract structure, enabling DLA to efficiently fulfill recurring medical supply needs across the Department of Defense's global healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/7/25 |